US Stock MarketDetailed Quotes

Biogen (BIIB)

Watchlist
  • 176.020
  • -4.520-2.50%
Close Apr 16 16:00 ET
  • 176.010
  • -0.010-0.01%
Post 19:56 ET
25.83BMarket Cap20.03P/E (TTM)

Biogen (BIIB) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
2.22%9.89B
-7.14%2.28B
2.79%2.53B
7.33%2.65B
6.13%2.43B
-1.62%9.68B
2.87%2.45B
-2.55%2.47B
0.36%2.46B
-7.00%2.29B
Operating revenue
2.22%9.89B
-7.14%2.28B
2.79%2.53B
7.33%2.65B
8.24%2.05B
-1.62%9.68B
-22.50%2.45B
10.77%2.47B
0.36%2.46B
-8.09%1.9B
Cost of revenue
4.06%2.4B
-15.08%495.5M
5.59%674.4M
10.81%605M
16.06%629.3M
-8.80%2.31B
-5.63%583.5M
-3.17%638.7M
-7.88%546M
-18.20%542.2M
Gross profit
1.64%7.49B
-4.67%1.78B
1.82%1.86B
6.34%2.04B
3.05%1.8B
0.87%7.37B
5.84%1.87B
-2.33%1.83B
2.98%1.92B
-2.88%1.75B
Operating expense
-1.33%5.02B
-0.23%1.4B
-3.86%1.25B
-1.64%1.19B
0.49%1.18B
-6.77%5.09B
8.34%1.4B
-20.28%1.3B
-2.70%1.21B
-8.74%1.17B
Selling and administrative expenses
1.24%2.43B
0.37%682.5M
1.09%594.8M
5.42%583.8M
-1.55%572.5M
-5.73%2.4B
11.75%680M
-25.35%588.4M
1.06%553.8M
-3.88%581.5M
Research and development costs
-10.19%1.78B
-0.76%509.4M
-15.52%436.1M
-21.05%399M
-2.54%434.1M
-19.02%1.98B
-7.40%513.3M
-29.89%516.2M
-13.49%505.4M
-21.94%445.4M
Depreciation amortization depletion
15.29%515M
-9.66%136.6M
4.14%135.7M
50.63%130.9M
42.78%111.8M
85.66%446.7M
97.39%151.2M
113.96%130.3M
64.27%86.9M
55.98%78.3M
-Depreciation and amortization
15.29%515M
-9.66%136.6M
4.14%135.7M
50.63%130.9M
42.78%111.8M
85.66%446.7M
97.39%151.2M
113.96%130.3M
64.27%86.9M
55.98%78.3M
Other operating expenses
14.07%290.2M
22.42%69.9M
25.83%87.2M
20.19%75M
-11.43%58.1M
16.27%254.4M
5.16%57.1M
37.23%69.3M
9.67%62.4M
14.89%65.6M
Operating profit
8.27%2.47B
-17.91%385.5M
15.99%606.5M
19.90%851.8M
8.26%625.2M
23.42%2.28B
-0.99%469.6M
122.70%522.9M
14.34%710.4M
11.64%577.5M
Net non-operating interest income expense
22.00%-142.5M
26.99%-30.3M
25.73%-35.8M
2.18%-40.3M
30.31%-36.1M
-717.23%-182.7M
13.00%-41.5M
-250.16%-48.2M
-253.73%-41.2M
-381.52%-51.8M
Non-operating interest income
84.91%125M
101.08%37.2M
172.41%31.6M
60.70%32.3M
37.36%23.9M
-75.55%67.6M
-22.27%18.5M
-87.90%11.6M
-73.52%20.1M
-78.49%17.4M
Non-operating interest expense
6.87%267.5M
12.50%67.5M
12.71%67.4M
18.43%72.6M
-13.29%60M
1.38%250.3M
-16.08%60M
-6.27%59.8M
24.85%61.3M
10.72%69.2M
Other net income (expense)
-301.67%-770M
-201.02%-411.2M
43.46%-13.4M
-328.81%-67.5M
-356.32%-277.9M
66.98%-191.7M
-1.19%-136.6M
94.19%-23.7M
-50.83%29.5M
37.47%-60.9M
Gain on sale of security
63.21%-48.3M
103.23%2.7M
-141.23%-14.1M
87.86%-5.1M
20.50%-31.8M
61.56%-131.3M
-293.87%-83.5M
110.40%34.2M
-143.43%-42M
54.75%-40M
Special income (charges)
-412.29%-746.4M
-198.11%-426.6M
73.56%-15.1M
-180.41%-59.1M
-1,192.63%-245.6M
39.11%-145.7M
-19.95%-143.1M
24.87%-57.1M
313.66%73.5M
-97.92%-19M
-Less:Restructuring and merger&acquisition
41.97%82.2M
28.26%11.8M
-57.52%13M
89.39%12.5M
290.43%44.9M
-73.54%57.9M
-90.69%9.2M
-59.74%30.6M
-80.81%6.6M
19.79%11.5M
-Less:Impairment of capital assets
--52.9M
----
----
----
----
--0
----
----
----
----
-Less:Other special charges
596.24%611.3M
698.90%361.9M
-92.08%2.1M
448.24%46.6M
2,576.00%200.7M
328.29%87.8M
--45.3M
--26.5M
--8.5M
--7.5M
-Gain on sale of business
----
----
----
----
----
--0
----
----
----
----
-Gain on sale of property,plant,equipment
----
----
--0
--0
----
--0
---88.6M
--0
--88.6M
----
Other non- operating income (expenses)
-71.04%24.7M
-85.89%12.7M
2,075.00%15.8M
-65.00%-3.3M
73.68%-500K
21,225.00%85.3M
1,536.36%90M
76.47%-800K
13.04%-2M
-416.67%-1.9M
Income before tax
-18.34%1.56B
-119.21%-56M
23.57%557.3M
6.48%744M
-33.05%311.2M
46.98%1.91B
-0.03%291.5M
419.41%451M
-1.33%698.7M
6.05%464.8M
Income tax
-3.73%263.6M
-128.63%-7.1M
45.28%90.8M
-5.13%109.2M
-0.98%70.7M
102.37%273.8M
-41.92%24.8M
185.73%62.5M
0.26%115.1M
40.83%71.4M
Earnings from equity interest net of tax
----
----
----
----
----
--0
----
----
----
----
Net income
-20.79%1.29B
-118.34%-48.9M
20.08%466.5M
8.77%634.8M
-38.87%240.5M
40.53%1.63B
7.15%266.7M
668.81%388.5M
-1.63%583.6M
1.50%393.4M
Net income continuous Operations
-20.79%1.29B
-118.34%-48.9M
20.08%466.5M
8.77%634.8M
-38.87%240.5M
40.53%1.63B
7.15%266.7M
668.81%388.5M
-1.63%583.6M
1.50%393.4M
Minority interest income
0
0
0
0
0
0
Net income attributable to the parent company
-20.79%1.29B
-118.34%-48.9M
20.08%466.5M
8.77%634.8M
-38.87%240.5M
40.57%1.63B
6.81%266.7M
670.48%388.5M
-1.35%583.6M
1.42%393.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-20.79%1.29B
-118.34%-48.9M
20.08%466.5M
8.77%634.8M
-38.87%240.5M
40.57%1.63B
6.81%266.7M
670.48%388.5M
-1.35%583.6M
1.42%393.4M
Basic earnings per share
-21.23%8.83
-118.03%-0.33
19.10%3.18
7.98%4.33
-39.11%1.65
39.78%11.21
6.40%1.83
668.09%2.67
-1.96%4.01
0.74%2.71
Diluted earnings per share
-21.38%8.79
-118.03%-0.33
19.17%3.17
8.25%4.33
-39.26%1.64
40.28%11.18
7.02%1.83
665.96%2.66
-1.72%4
1.12%2.7
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 2.22%9.89B-7.14%2.28B2.79%2.53B7.33%2.65B6.13%2.43B-1.62%9.68B2.87%2.45B-2.55%2.47B0.36%2.46B-7.00%2.29B
Operating revenue 2.22%9.89B-7.14%2.28B2.79%2.53B7.33%2.65B8.24%2.05B-1.62%9.68B-22.50%2.45B10.77%2.47B0.36%2.46B-8.09%1.9B
Cost of revenue 4.06%2.4B-15.08%495.5M5.59%674.4M10.81%605M16.06%629.3M-8.80%2.31B-5.63%583.5M-3.17%638.7M-7.88%546M-18.20%542.2M
Gross profit 1.64%7.49B-4.67%1.78B1.82%1.86B6.34%2.04B3.05%1.8B0.87%7.37B5.84%1.87B-2.33%1.83B2.98%1.92B-2.88%1.75B
Operating expense -1.33%5.02B-0.23%1.4B-3.86%1.25B-1.64%1.19B0.49%1.18B-6.77%5.09B8.34%1.4B-20.28%1.3B-2.70%1.21B-8.74%1.17B
Selling and administrative expenses 1.24%2.43B0.37%682.5M1.09%594.8M5.42%583.8M-1.55%572.5M-5.73%2.4B11.75%680M-25.35%588.4M1.06%553.8M-3.88%581.5M
Research and development costs -10.19%1.78B-0.76%509.4M-15.52%436.1M-21.05%399M-2.54%434.1M-19.02%1.98B-7.40%513.3M-29.89%516.2M-13.49%505.4M-21.94%445.4M
Depreciation amortization depletion 15.29%515M-9.66%136.6M4.14%135.7M50.63%130.9M42.78%111.8M85.66%446.7M97.39%151.2M113.96%130.3M64.27%86.9M55.98%78.3M
-Depreciation and amortization 15.29%515M-9.66%136.6M4.14%135.7M50.63%130.9M42.78%111.8M85.66%446.7M97.39%151.2M113.96%130.3M64.27%86.9M55.98%78.3M
Other operating expenses 14.07%290.2M22.42%69.9M25.83%87.2M20.19%75M-11.43%58.1M16.27%254.4M5.16%57.1M37.23%69.3M9.67%62.4M14.89%65.6M
Operating profit 8.27%2.47B-17.91%385.5M15.99%606.5M19.90%851.8M8.26%625.2M23.42%2.28B-0.99%469.6M122.70%522.9M14.34%710.4M11.64%577.5M
Net non-operating interest income expense 22.00%-142.5M26.99%-30.3M25.73%-35.8M2.18%-40.3M30.31%-36.1M-717.23%-182.7M13.00%-41.5M-250.16%-48.2M-253.73%-41.2M-381.52%-51.8M
Non-operating interest income 84.91%125M101.08%37.2M172.41%31.6M60.70%32.3M37.36%23.9M-75.55%67.6M-22.27%18.5M-87.90%11.6M-73.52%20.1M-78.49%17.4M
Non-operating interest expense 6.87%267.5M12.50%67.5M12.71%67.4M18.43%72.6M-13.29%60M1.38%250.3M-16.08%60M-6.27%59.8M24.85%61.3M10.72%69.2M
Other net income (expense) -301.67%-770M-201.02%-411.2M43.46%-13.4M-328.81%-67.5M-356.32%-277.9M66.98%-191.7M-1.19%-136.6M94.19%-23.7M-50.83%29.5M37.47%-60.9M
Gain on sale of security 63.21%-48.3M103.23%2.7M-141.23%-14.1M87.86%-5.1M20.50%-31.8M61.56%-131.3M-293.87%-83.5M110.40%34.2M-143.43%-42M54.75%-40M
Special income (charges) -412.29%-746.4M-198.11%-426.6M73.56%-15.1M-180.41%-59.1M-1,192.63%-245.6M39.11%-145.7M-19.95%-143.1M24.87%-57.1M313.66%73.5M-97.92%-19M
-Less:Restructuring and merger&acquisition 41.97%82.2M28.26%11.8M-57.52%13M89.39%12.5M290.43%44.9M-73.54%57.9M-90.69%9.2M-59.74%30.6M-80.81%6.6M19.79%11.5M
-Less:Impairment of capital assets --52.9M------------------0----------------
-Less:Other special charges 596.24%611.3M698.90%361.9M-92.08%2.1M448.24%46.6M2,576.00%200.7M328.29%87.8M--45.3M--26.5M--8.5M--7.5M
-Gain on sale of business ----------------------0----------------
-Gain on sale of property,plant,equipment ----------0--0------0---88.6M--0--88.6M----
Other non- operating income (expenses) -71.04%24.7M-85.89%12.7M2,075.00%15.8M-65.00%-3.3M73.68%-500K21,225.00%85.3M1,536.36%90M76.47%-800K13.04%-2M-416.67%-1.9M
Income before tax -18.34%1.56B-119.21%-56M23.57%557.3M6.48%744M-33.05%311.2M46.98%1.91B-0.03%291.5M419.41%451M-1.33%698.7M6.05%464.8M
Income tax -3.73%263.6M-128.63%-7.1M45.28%90.8M-5.13%109.2M-0.98%70.7M102.37%273.8M-41.92%24.8M185.73%62.5M0.26%115.1M40.83%71.4M
Earnings from equity interest net of tax ----------------------0----------------
Net income -20.79%1.29B-118.34%-48.9M20.08%466.5M8.77%634.8M-38.87%240.5M40.53%1.63B7.15%266.7M668.81%388.5M-1.63%583.6M1.50%393.4M
Net income continuous Operations -20.79%1.29B-118.34%-48.9M20.08%466.5M8.77%634.8M-38.87%240.5M40.53%1.63B7.15%266.7M668.81%388.5M-1.63%583.6M1.50%393.4M
Minority interest income 000000
Net income attributable to the parent company -20.79%1.29B-118.34%-48.9M20.08%466.5M8.77%634.8M-38.87%240.5M40.57%1.63B6.81%266.7M670.48%388.5M-1.35%583.6M1.42%393.4M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -20.79%1.29B-118.34%-48.9M20.08%466.5M8.77%634.8M-38.87%240.5M40.57%1.63B6.81%266.7M670.48%388.5M-1.35%583.6M1.42%393.4M
Basic earnings per share -21.23%8.83-118.03%-0.3319.10%3.187.98%4.33-39.11%1.6539.78%11.216.40%1.83668.09%2.67-1.96%4.010.74%2.71
Diluted earnings per share -21.38%8.79-118.03%-0.3319.17%3.178.25%4.33-39.26%1.6440.28%11.187.02%1.83665.96%2.66-1.72%41.12%2.7
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Trump stated on the 15th that the US-Iran war is 'about to end,' with an agreement expected to be reached before the end of April. However, Show More